FDA Brief

Warning letters Food

FDA warning letter to

West Coast Laboratories, Inc.

High riskIssued Jun 12, 2024Posted Jul 23, 2024Division of Human and Animal Food Operations West V

FDA warned West Coast Laboratories over dietary supplements made without required manufacturing controls and illegally labeled.

What happened

FDA inspected the facility in Gardena, CA, from October 3 through October 24, 2023, and provided a Form FDA 483 at the close. FDA found violations of current good manufacturing practice (CGMP) for dietary supplements, including missing ingredient identity testing, missing component specifications, use of ingredients before quality control release from quarantine, and shipping before quality control release. FDA also found the Calcium Pyruvate, Chromium Picolinate, and CalComplex labels misbranded under section 403.

What FDA found

  1. The company did not test the identity of dietary ingredients before using them.

    21 CFR 111.75(a)(1)(i)
  2. The company lacked component specifications needed to ensure the purity, strength, and composition of its supplements.

    21 CFR 111.70(b)(2)
  3. Quality control approved and released a Calcium Pyruvate batch even though an ingredient had an out-of-specification calcium result.

    21 CFR 111.123(b)(1)
  4. The company used ingredients before quality control released them from quarantine and shipped finished supplements before quality control release.

    21 CFR 111.120(e) and 21 CFR 111.127(h)
  5. Manufacturing and batch records lacked required written instructions, actual yields, component identities, label references, and quality review signoffs.

    21 CFR 111.205; 21 CFR 111.210(h)(1) and (h)(3); 21 CFR 111.260
  6. The labels lacked a domestic adverse-event contact and did not follow required Supplement Facts order, format, and daily value rules.

    section 403(y) and section 403(q)(5)(F) of the Act [21 U.S.C. 343(y), 343(q)(5)(F)]; 21 CFR 101.36 and 101.9

What FDA wants

FDA tells the company to notify it in writing within 15 working days of receipt of the letter of steps taken to address the violations and prevent recurrence, with related documentation, or explain why corrective actions cannot be completed and when they will be.

Who should pay attention

  • brands that buy finished dietary supplements from this contract manufacturer
  • retailers and distributors selling Calcium Pyruvate, Chromium Picolinate, or CalComplex
  • quality teams at dietary supplement manufacturers with similar ingredient and release controls

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Penn Herb Company, Ltd.

    FDA warned Penn Herb Company over CGMP violations and an undeclared tree-nut allergen in three dietary supplements.

    High risk
  2. Psyched Wellness Ltd.

    FDA warned Psyched Wellness that its Calm, Calmer and Santa Amanita muscaria supplements are adulterated new-dietary-ingredient products.

    High risk
  3. Wellmill, LLC dba Vitamix Laboratories

    FDA warned Vitamix Laboratories that its juice-with-probiotics products were adulterated because it lacked required hazard controls and a 5-log pathogen reduction.

    High risk
  4. American Pharma Mfg. Inc.

    FDA warns American Pharma Mfg. of serious dietary supplement manufacturing violations at its Ontario, CA facility.

    High risk